MKKGY
Price
$26.43
Change
+$0.61 (+2.36%)
Updated
Aug 15 closing price
Capitalization
56.5B
88 days until earnings call
SUPN
Price
$42.69
Change
+$0.52 (+1.23%)
Updated
Aug 15 closing price
Capitalization
2.39B
86 days until earnings call
Interact to see
Advertisement

MKKGY vs SUPN

Header iconMKKGY vs SUPN Comparison
Open Charts MKKGY vs SUPNBanner chart's image
Merck KGaA
Price$26.43
Change+$0.61 (+2.36%)
Volume$82.3K
Capitalization56.5B
Supernus Pharmaceuticals
Price$42.69
Change+$0.52 (+1.23%)
Volume$996.29K
Capitalization2.39B
MKKGY vs SUPN Comparison Chart in %
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. SUPN commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and SUPN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (MKKGY: $26.43 vs. SUPN: $42.69)
Brand notoriety: MKKGY and SUPN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKKGY: 52% vs. SUPN: 111%
Market capitalization -- MKKGY: $56.5B vs. SUPN: $2.39B
MKKGY [@Pharmaceuticals: Generic] is valued at $56.5B. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.39B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, SUPN is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 5 bullish TA indicator(s).

  • MKKGY’s TA Score: 5 bullish, 3 bearish.
  • SUPN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both MKKGY and SUPN are a good buy in the short-term.

Price Growth

MKKGY (@Pharmaceuticals: Generic) experienced а +4.10% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +3.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

SUPN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($56.5B) has a higher market cap than SUPN($2.39B). SUPN has higher P/E ratio than MKKGY: SUPN (37.12) vs MKKGY (17.12). SUPN YTD gains are higher at: 18.059 vs. MKKGY (-6.034). MKKGY has higher annual earnings (EBITDA): 6.04B vs. SUPN (180M). MKKGY has more cash in the bank: 1.62B vs. SUPN (464M). SUPN has less debt than MKKGY: SUPN (32.3M) vs MKKGY (8.7B). MKKGY has higher revenues than SUPN: MKKGY (21.3B) vs SUPN (668M).
MKKGYSUPNMKKGY / SUPN
Capitalization56.5B2.39B2,360%
EBITDA6.04B180M3,357%
Gain YTD-6.03418.059-33%
P/E Ratio17.1237.1246%
Revenue21.3B668M3,189%
Total Cash1.62B464M349%
Total Debt8.7B32.3M26,929%
FUNDAMENTALS RATINGS
MKKGY vs SUPN: Fundamental Ratings
MKKGY
SUPN
OUTLOOK RATING
1..100
5021
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
9345
SMR RATING
1..100
6979
PRICE GROWTH RATING
1..100
6041
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (23) in the null industry is somewhat better than the same rating for SUPN (78) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for MKKGY (93) in the null industry. This means that SUPN’s stock grew somewhat faster than MKKGY’s over the last 12 months.

MKKGY's SMR Rating (69) in the null industry is in the same range as SUPN (79) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's Price Growth Rating (41) in the Pharmaceuticals Other industry is in the same range as MKKGY (60) in the null industry. This means that SUPN’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (91) in the null industry is in the same range as SUPN (100) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYSUPN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 24 days ago
61%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 6 days ago
64%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETON17.040.34
+2.04%
Eton Pharmaceuticals
YHNA10.450.01
+0.10%
YHN Acquisition I Ltd
AVAV246.65-3.08
-1.23%
AeroVironment
LFST5.44-0.14
-2.51%
LifeStance Health Group
VERO2.32-0.13
-5.31%
Venus Concept

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+2.36%
MKGAF - MKKGY
49%
Loosely correlated
+1.94%
AMPH - MKKGY
25%
Poorly correlated
-1.26%
ZTS - MKKGY
25%
Poorly correlated
+0.69%
SUPN - MKKGY
25%
Poorly correlated
+1.23%
INDV - MKKGY
24%
Poorly correlated
+1.25%
More